Compare Autodesk Inc (ADSK) vs BridgeBio Pharma Inc (BBIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Autodesk Inc vs BridgeBio Pharma Inc — how do they compare? Autodesk Inc trades at $247.5 (market cap $54.07B), while BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B). The key difference: Autodesk Inc is far larger — about 3.3× BridgeBio Pharma Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Autodesk Inc nearer its low. Which is the better fit depends on your goals.
| ADSK | BBIO | |
|---|---|---|
Market Cap | $54.07B | $16.61B |
Sector | Technology | Health |
52-Week High | $326.79 | $90.17 |
52-Week Low | $187.72 | $47.29 |
Enterprise Value | $53.87B | $18.16B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Autodesk Inc
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction.
Read more on ADSK →About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →
